November 25, 2024
View in browser SIGN UP

Big4Bio:SFBay

EDITOR'S NOTE: Big4Bio newsletters will not be published Nov 27th-29th; they will resume distribution on Monday, Dec 2nd.

* - may be subscription-only

Press Releases

  • Agilent: New Organizational Structure to Support Its Market-Focused Strategy More
  • Blue Lake and CyanVac: Positive Phase 2a Data for Intranasal COVID-19 Vaccine Candidate More
  • BridgeBio: Attruby (acoramidis), a Near Complete TTR Stabilizer (≥90%), Approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients More More More More*
  • LifeSignals: Receives FDA 510(k) Approval for UbiqVue 2A Multiparameter System More
  • Scribe Therapeutics: Preclinical Data Validating Its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024 More
  • Tenaya Therapeutics: Doses First Patient in RIDGE-1 Phase 1b Clinical Trial of TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy More

Spotlight:




Looking to engage a CRO? Do this first.
 

Section Sponsor:

Danforth Advisors

Financial News

  • DURECT: Sale of ALZET Product Line to Lafayette Instrument Co. for $17.5 Million More
  • Gilead Buys Experimental HIV Vaccines From a Small Barcelona Biotech More* More
  • Niterra Ventures Company: Invests $18M Additional Funding in Neoplas Med GmbH More
  • Setting the Stage for Productive Partnering Talks During JPM Week Podcast

Spotlight:



Investment Banking Advisory to the Life Science Industry

 

Section Sponsor:

Aquilo Partners
Pre-JPM Partnering Week - Virtual business development & licensing event Dec 2nd - 6th, 2024

Media/Misc Coverage

  • Stanford: How This Doctor is Combatting a Gravely Serious Clotting Condition More
  • Subscribe to LifeSci Startup for Updates on US Startups More
  • 23andMe: Are You Genetically Connected to Early Colonial Americans? More

Spotlight:



Move Faster In Our Flexible, Research-Ready Vivarium Space
 

Section Sponsor:

cradl Logo

Companies

SECTION SPONSOR: BioPharmGuy Logo
  • Big4Bio:SFBay Life Science Company Directory More

NOTE: EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS

Event Center

  • Biotech Networks Speed Networking San Francisco Dec 2
  • Pre-JPM Partnering Week Dec 2-6
  • The Art of Fundraising Dec 5
  • Advocacy Abstract Dec 6
  • Advancing Drug Development Forum Dec 12
  • Meet the Leaders & Holiday Mixer Hosted by LSPA Board of Directors Dec 12
  • 2nd Innovation in Women's Health Pitch Competition Jan 13
  • **SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR**

Spotlight:



Pre-JPM Partnering Week
Dec 2-6


 

Section Sponsor:

Career Center

  • (NEW) OPPORTUNITY: Head of GLP Immunoanalytical Services - Marlborough, MA More
  • OPPORTUNITY: Senior Director of Business Development - Remote More
  • OPPORTUNITY: Vice President of North America Medical Affairs - MA More
  • OPPORTUNITY: Chief Financial Officer - Boston, MA More
  • OPPORTUNITY: General Manager & Site Head - Burlington, MA More
  • OPPORTUNITY: Director of Epidemiology - Bay Area, CA More
  • OPPORTUNITY: Vice President of Program Leadership - Boston (Hybrid) More
  • OPPORTUNITY: Vice President of Sales & Marketing, North America - Remote More

Spotlight:

Premier Executive Search and Talent Advisory Firm Slone Partners Launches Fractional Talent Service to Deliver On-Demand Leaders and Specialists

 

Section Sponsor:

slone

 

SF Bay Sponsors

Aquilo Partners
Danforth Advisors
CRADL Logo
Marsh Logo
Slone
Charles River Logo
LSN Logo
CHI
Equipnet
SDC Logo


You are receiving this email because you signed up for one of our newsletters at Big4Bio.com, signed up at one of our partner or sponsor events, or given as a gift subscription by your firm or organization.

Unsubscribe | Forward to a friend
Follow us on Twitter
Follow us on LinkedIn
Subscribe to us on YouTube
Follow us on Soundcloud

Big4Bio is delivered to industry executives and entrepreneurs DAILY

Big4Bio:SFBay, all rights reserved 2024